Scientific commercialization. US biotech in good health.

Research commercialization--SBIR is good business.

Market heats up for US biotech companies.

Economism and the commercialization of health care.

The scientific article and the good science.

Patent patterns in biotech.

Cannabis legalization and public health: legal niceties, commercialization and countercultures.

Peer review in scientific journals--what good is it?

Nanomedicine drug development: a scientific symposium entitled "Charting a roadmap to commercialization".

Biotech grows in Hong Kong.

Biotech vaccines' problematic promise.

Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.

2013--Biotech back in the saddle.

Bridging tech and biotech.

Mechanistic data in scientific public health decisions.

Role of scientific data in health decisions.

Communicating scientific evidence in qualified health claims.

Challenges and opportunities in graphene commercialization.

Biotech lobby pressure EC.

2Q14-Biotech corrected.

The price of good health.

Critiquing US health care.

Help yourself to good health?

Fourth-quarter biotech job picture.

Commercialization of biobanks.

Suggest Documents

Research commercialization--SBIR is good business.

Market heats up for US biotech companies.

Economism and the commercialization of health care.

The scientific article and the good science.

Patent patterns in biotech.

Cannabis legalization and public health: legal niceties, commercialization and countercultures.

Peer review in scientific journals--what good is it?

Nanomedicine drug development: a scientific symposium entitled "Charting a roadmap to commercialization".

Biotech grows in Hong Kong.

Biotech vaccines' problematic promise.

Centre for Commercialization of Regenerative Medicine: moving forward with regenerative medicine commercialization in Canada.

2013--Biotech back in the saddle.

Bridging tech and biotech.

Mechanistic data in scientific public health decisions.

Role of scientific data in health decisions.

Communicating scientific evidence in qualified health claims.

Challenges and opportunities in graphene commercialization.

Biotech lobby pressure EC.

2Q14-Biotech corrected.

The price of good health.

Critiquing US health care.

Help yourself to good health?

Fourth-quarter biotech job picture.

Commercialization of biobanks.

Scientific commercialization. US biotech in good health.

Recommend Documents

Follow Us